SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 10.63 | 9.61 | 8.95 | 9.01 | 5.70 |
What is the latest Profit After Tax (PAT) Margin ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 10.63 |
| Mar2024 | 9.61 |
| Mar2023 | 8.95 |
| Mar2022 | 9.01 |
| Mar2017 | 5.70 |
How is Profit After Tax (PAT) Margin of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 10.63 | 10.61 | |
| Mar2024 | 9.61 | 7.37 | |
| Mar2023 | 8.95 | -0.67 | |
| Mar2022 | 9.01 | 58.07 | |
| Mar2017 | 5.7 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,443.8 Cr | -1.7% | -7.7% | -23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,248.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,344.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,832.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,820.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,877.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.7% |
-7.7% |
-23.1% |
| SENSEX | -0.6% |
1.4% |
7.7% |
You may also like the below Video Courses